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Summary
Background: Patient-reported outcome measures are required to measure asthma control.
The Asthma Control Test (ACT) is one such measure which was used in the AIRMAG study, a
general population study of asthma in the Maghreb. Three dialectal Arabic versions of the
ACT (Algerian, Moroccan and Tunisian) were developed.
Objective: To perform a psychometric evaluation of the properties of dialectal Arabic
versions of the ACT used in the AIRMAG study.
Methods: The test data came from 624 adult subjects in a random general population
sample in Algeria, Morocco and Tunisia. The internal consistency of the ACT was analysed
using Cronbach’s a coefﬁcient. The factorial structure was explored by primary component
analysis with varimax rotation. Test-retest reproducibility was assessed in a subgroup of 61
subjects. Face and discriminant validity were assessed.
Results: Cronbach’s a coefﬁcient ranged from 0.58 for the Algerian version to 0.67 for the
Moroccan version. The ‘use-of-rescue-treatment’ item was identiﬁed as discordant, since
its removal resulted in an increase in Cronbach’s a coefﬁcient. The discordance of this
item was conﬁrmed by primary component analysis, where the four remaining items were
aligned along a single dimension, and the ‘use-of-rescue-treatment’ item offset along a
second dimension. Test and retest scores were well correlated (r = 0.704). The ACT showed
good face and discriminant validity.
Conclusions: The ACT is a valid measure of asthma control in a North African context,
although its internal consistency is compromised by the ‘use-of-rescue-treatment’ item,
probably due to limited access to care and use of short-acting b-agonists.
© 2009 Published by Elsevier Ltd.
Introduction
The Asthma Control Test 1 is one of a number of patient-
reported outcome measures designed to measure control
of asthma. Maintaining adequate asthma control is the
goal of asthma management, and contemporary treatment
guidelines 2 recommend physicians to adjust therapy with
respect to residual symptoms and lung function in order
to achieve and maintain adequate control. Nonetheless,
in everyday practice, asthma remains poorly controlled in
a large proportion of patients 3 6. It is thus important to
have simple, rapid-to-complete and accurate assessment
*Tel: +971 4 332 1070; fax: +971 4 332 3071
E-mail address: abdelkader.a.el-hasnaoui@gsk.com
(A. El Hasnaoui).
tools to collect information from the patient on asthma
control over the past weeks 7. The ACT was designed to
fulﬁl this need and has subsequently been validated as a
useful tool for identifying patients whose asthma was poorly
controlled according to the Global Initiative for Asthma
(GINA) criteria and who were thus in need of a change
in therapy 8.
The ACT is a ﬁve-item questionnaire that was developed
in the United States by reduction of a 22-item proto-
questionnaire using stepwise multivariate analysis to iden-
tify times that discriminated physician-rated asthma control
with the greatest sensitivity 1. The ACT assesses control over
the preceding four weeks. Psychometric validation of the
ﬁve-item ACT has shown it to have satisfactory internal
consistency and construct validity 1. As well as its use in
0954-6111/$ see front matter © 2009 Published by Elsevier Ltd.
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Table 1. Asthma Control Test
1. During the past 4 weeks, how often did your asthma prevent you from getting as much done at work, school or home?
2. During the past 4 weeks, how often have you had shortness of breath?
3. During the past 4 weeks, how often did your asthma symptoms (wheezing, coughing, shortness of breath, chest tightness
or pain) wake you up at night or earlier than usual in the morning?
4. During the past 4 weeks, how often have you used your rescue inhaler (such as salbutamol, terbutaline)?
5. How would you rate your asthma control during the past 4 weeks?
everyday practice, the ACT has been used as an outcome
measure in clinical trials 9,10, as a research tool to evaluate,
for example, the relationship between asthma control
and healthcare resource utilisation 11, quality of life 11 13,
sleep disturbances 14, or anxiodepressive comorbidity 15 and
treatment 16, as well as in epidemiological studies to
measure the extent to which asthma control is achieved 6
and to evaluate disease perceptions 17,18.
Given that cultural factors could potentially inﬂuence
responses to certain questions of the ACT, it is important
that the questionnaire be validated cross-culturally, partic-
ularly when translated into other languages. Psychometric
validation studies have been published for the Spanish 19,
Chinese 20, Arabic 21 and Korean 12 versions of the ACT, and
validated versions are also available in French, German and
Italian 8.
We have recently used the ACT to assess asthma control in
the AIRMAG study, a large epidemiological study of asthma
in the Maghreb region of North Africa (Morocco, Algeria and
Tunisia) 22,23. The present report describes the psychometric
properties of the ACT in this population.
METHODS
Data collection
The test data for this validation study came from 624 adult
subjects included in the AIRMAG study of asthma prevalence
and control conducted in a random sample of the general
population of Algeria, Morocco and Tunisia between January
2008 and May 2008. The methodology of the study has
been described in detail in an accompanying article in this
supplement 23, to which the reader is referred for more
information. Brieﬂy, individuals with asthma were identiﬁed
using a screening questionnaire administered over the
telephone to household members contacted on the basis of
a randomly-generated list of telephone numbers. Telephone
interviews were conducted by local interviewers using the
CAPI (Computer Assisted Personal Interview) method and
CONVERSO® software (developed by Conversoft® France).
Since certain berberophone populations in the Maghreb may
not feel comfortable responding in Arabic, the interviewer
could conduct the telephone interview in French or in
Berber language if necessary. Subjects who met criteria for
asthma were questioned in detail to collect information
on the frequency and severity of symptoms, impact
on activities of everyday life, treatments, monitoring,
asthma control and knowledge about asthma. The ACT was
administered to all adult subjects. In addition, asthma
control was operationally deﬁned using an algorithm based
on answers to questions relating to the GINA criteria 2 for
asthma control, as described elsewhere 22.
Asthma Control Test
The ACT is a questionnaire containing ﬁve items (Table 1)
which can each be rated on a ﬁve point Likert scale. The
total possible score is thus 25. On the basis of the ACT score,
subjects can be assigned to one of three control categories,
namely optimally controlled asthma (ACT score = 25),
partially controlled asthma (ACT score between 20 and 24
inclusive) or uncontrolled asthma (ACT score 19). The
validated French translation of the ACT 8,24 was translated
locally into the different Algerian, Moroccan and Tunisian
dialectal variants of Arabic spoken in the Maghreb. Three
slightly different lexical versions of the questionnaire were
thus used.
Psychometric validation
The internal consistency of the ACT questionnaire was
analysed using Cronbach’s a coefﬁcient. Individual items
were then successively removed from the score in order
to identify potentially discordant items. The correlation
between scores on the individual items was also evaluated
using linear regression analysis of item pairs.
The factorial structure of the scale was explored
by primary component analysis with varimax rotation.
Eigenvalues were calculated for the dimensions identiﬁed
and a two-dimensional factorial map was generated,
representing the inertia in the data explained by the
analysis. The eigenvector for each ACT item in each country
was displayed on this factorial map.
To assess reproducibility, a subgroup of 61 subjects
were telephoned one week after the initial contact and
administered the ACT a second time. Due to the relatively
small sample size, data were pooled across the three
versions of the questionnaire for this analysis. Test-retest
reproducibility was assessed by calculation of an intra-
class correlation coefﬁcient. In addition, consistency of the
categorical control level (optimally-, partially- and poorly-
controlled) between the two measures was assessed by
determination of the weighted kappa coefﬁcient.
In the absence of a gold standard for asthma control,
face validity was assessed using the correlation between
the ACT score and asthma features that are expected to
be correlated with control. These included overall health
status, asthma inconvenience, limitations in sport and
leisure activities, limitations in normal physical activity,
limitations in professional activities, limitations in social
activities, limitations in sleep, limitations in lifestyle and
limitations in household tasks. These correlations were
assessed using linear regression between the ACT scores and
Likert scores for items collected in the interview and are
presented as Pearson correlation coefﬁcients.
Discriminant validity, deﬁned here as the capacity of
the instrument to differentiate between groups which
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Table 2. Response modality distribution for the ﬁve items of the Asthma Control Test in the three Maghreb countries
Algerian version (N = 154) Moroccan version (N = 236) Tunisian version (N = 234)
Limitation on activities All the time
Most of time
Sometimes
Rarely
Never
17 (12%)
9 (6.3%)
39 (27.5%)
12 (8.5%)
65 (45.8%)
32 (14.1%)
35 (15.4%)
37 (16.3%)
60 (26.4%)
63 (27.8%)
45 (19.4%)
33 (14.2%)
38 (16.4%)
48 (20.7%)
68 (29.3%)
Breathlessness More than once a day
Once a day
3 6 times per week
1 2 times per week
Never
31 (20.5%)
18 (11.9%)
21 (13.9%)
37 (24.5%)
44 (29.1%)
49 (21.8%)
39 (17.3%)
26 (11.6%)
59 (26.2)
52 (23.1)
22 (9.5%)
30 (12.9%)
37 (15.9%)
57 (24.6%)
86 (37.1%)
Nocturnal awakenings 4 nights per week
2 3 nights per week
Once a week
Once or twice in all
Never
38 (25%)
27 (17.8%)
23 (15.1%)
30 (19.7%)
34 (22.4%)
47 (20.9%)
40 (17.8%)
22 (9.8%)
43 (19.1%)
73 (32.4%)
41 (17.7%)
30 (12.9%)
21 (9.1%)
51 (22%)
89 (38.4%)
Use of rescue treatment 3 times a day
Once or twice a day
2 3 times a week
At least once a week
Never
23 (15.1%)
34 (22.4%)
10 (6.6%)
13 (8.6%)
72 (47.4%)
40 (18%)
68 (30.6%)
22 (9.9%)
18 (8.1%)
74 (33.3%)
40 (17.2%)
54 (23.3%)
16 (6.9%)
24 (10.3%)
98 (42.2%)
Self-rated asthma
control during the
previous four weeks
Totally controlled
Well controlled
Optimally controlled
Little controlled
Uncontrolled
25 (16.6%)
35 (23.2%)
50 (33.1%)
23 (15.2%)
18 (11.9%)
29 (12.7%)
62 (27.2%)
29 (12.7%)
95 (41.7%)
13 (5.7%)
41 (17.7%)
85 (36.6%)
66 (28.4%)
18 (7.8%)
22 (9.5%)
were expected to differ with respect to asthma control
was assessed with respect to two criteria. Firstly, ACT
scores were compared between three categories of
patient assigned to one of three control categories
(controlled, partially controlled and uncontrolled) using an
operational GINA-based algorithm 22. Secondly, ACT scores
were compared between three groups of patients who
differed in their perceptions of the evolution of their
asthma since diagnosis, namely those who considered that
their asthma had improved, those who considered that it
had deteriorated and those who considered that it had
remained stable. These comparisons were performed using
analysis of variance.
Two-sided tests were used throughout and a probability
level of p < 0.05 was considered signiﬁcant. All data were
controlled, validated and analysed centrally (Kappa Sante´,
Paris, France) using SAS software, version 9.1 (SAS Institute,
Cary, USA).
Results
Study sample
Overall, 624 adults (154 in Algeria, 236 in Morocco and
234 in Tunisia) fulﬁlled the screening criteria for asthma
and provided a completed ACT questionnaire. The mean
age of the subjects was 40.4 years and women were
over-represented (gender ratio: 1:1.46). The characteristics
of the study sample are described in more detail in an
accompanying article 22. A subset of 61 patients was used
to evaluate the reproducibility of the questionnaire (20 in
Algeria, 21 in Morocco and 20 in Tunisia).
Distribution of ACT item response categories
The distribution of the different response modalities for
each of the ﬁve ACT questions for each country are
presented in Table 2. The item with the highest response
rate for the worst possible control level was the question
related to nocturnal awakenings and that with the highest
response rate for the lowest possible control level was that
related to limitations on activities. Concerning the question
on self-rated control, 45.3% of the total sample considered
themselves well or totally controlled and 8.7% considered
themselves uncontrolled. Response distributions differed
between countries at a signiﬁcance level of 0.01 (c2 test)
for all items except nocturnal awakenings ( p = 0.045) and
use of rescue treatments ( p = 0.204). For this reason, all
the subsequent analyses were performed for each country
individually, as well as for the entire sample population
when appropriate. In general, items were scored higher
(better control) in Tunisia than in the other two countries.
Internal consistency
Internal consistency was determined with the alpha
coefﬁcient of Cronbach, which was estimated to be 0.58 for
Algeria, 0.67 for Morocco and 0.63 for Tunisia. In order to
evaluate whether any individual item was discordant with
the rest, thus diminishing the overall internal consistency,
each item was removed in turn from the determination
of Cronbach’s a coefﬁcient. In each case, removal of an
item resulted in a decrease in internal consistency, with
the exception of the ‘use of rescue treatment’ item, whose
removal lead to an increase in overall internal consistency
(Table 3). The ‘use of rescue treatment’ item was thus
identiﬁed as the discordant item.
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Table 3. Effect of individual item removal on the internal consistency of the Asthma Control Test
Item removed Algerian version Moroccan version Tunisian version
Limitation on activities 0.51 0.55 0.45
Breathlessness 0.42 0.58 0.51
Nocturnal awakenings 0.46 0.57 0.53
Use of rescue treatment 0.62 0.69 0.73
Self-rating of asthma control during the previous four weeks 0.56 0.65 0.62
Table 4. Correlation between individual item scores of the Asthma Control Test a
Limitation on
activities
Breathlessness Nocturnal
awakenings
Use of rescue
treatment
Self-rated asthma control
during the previous four
weeks
Limitation on activities 1
Breathlessness 0.41
p < 0.001
1
Nocturnal awakenings 0.42
p < 0.001
0.43
p < 0.001
1
Use of rescue treatment 0.16
p < 0.001
0.20
p < 0.001
0.13
p = 0.002
1
Self-rated asthma control during the previous four weeks 0.32
p < 0.001
0.28
p < 0.001
0.26
p < 0.001
-0.002
p = 0.98
1
a Data are presented as Pearson correlation coefﬁcients and associated probability values obtained from linear regression analysis.
Correlation between the different items of the ques-
tionnaire was also evaluated by linear regression analysis
between scores for each item. Inter-item correlation was
reasonable except for the ‘use of rescue treatment’ that
was poorly correlated with the other questionnaire items
(Table 4).
Primary component analysis
The factorial structure of the ACT was evaluated using
primary component analysis. This identiﬁed two dimensions
with an Eigenvalue >1, one of which accounted for around
40% of the total variance in the data set, and the
other for around 20%. The corresponding factorial map,
showing the Eigenvectors for each item for each version
of the questionnaire, is presented in Fig. 1. On the major
dimension (horizontal axis) the ‘use of rescue treatment’
item separated from the remaining four items, which
grouped together on this dimension. These four items were
spread out along the minor dimension, which discriminated
between the ‘use of rescue treatment’ item (Eigenvector
on axis 2 > 0.85) and the ‘self-rated asthma control’ item
(Eigenvector on axis 20.25). The factorial structure of the
dataset was qualitatively similar for all three countries. The
weighting of the different items on the major and minor
dimension is presented for each item in Table 5.
Reproducibility
Test-retest reproducibility was evaluated in a subgroup of
61 patients with a seven-day interval between the test and
retest. Test and retest scores were well correlated with one
another according to linear regression analysis (r = 0.704).
The test-retest matrix is presented in Fig. 2. A categorical
analysis of reproducibility was also performed in which the
control category (totally controlled, partially controlled and
uncontrolled) was compared between test and retest using
weighted kappa coefﬁcients. The overall concordance was
moderate (ú = 0.55 [95%CI: 0.36 to 0.74]).
Face validity
The relationship between ACT scores and a number of other
variables with a priori associations with asthma control
and for which data was collected during the interview was
assessed by linear regression analysis (Table 6). For all
three versions, the strongest correlations were observed for
overall health status, asthma inconvenience and limitations
in lifestyle.
Discriminant validity
The relationship between the ACT score and a level of
control assigned operationally using an algorithm based on
questions relating to the GINA criteria for asthma control
was evaluated (Table 7). For each of the three versions of
the questionnaire, a highly signiﬁcant association between
the two variables was observed ( p < 0.001; ANOVA), with
mean ACT scores being close to twofold higher in the
controlled group compared to the uncontrolled group as
deﬁned by the operational deﬁnition.
A signiﬁcant association between ACT scores and
perceived change in asthma status was detected for all
versions of the questionnaire, with subjects reporting that
their asthma had improved since diagnosis presenting higher
scores (better control) than those who reported that their
asthma had worsened (Table 8).
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Fig. 1. Factorial map of the distribution of the ﬁve items of the Asthma Control Test identiﬁed by primary component analysis. Each item is numbered
as follows: 1: limitation on activities; 2: breathlessness; 3: nocturnal awakenings; 4: use of rescue treatment; 5: self-rated asthma control during the
previous four weeks.
Table 5. Factorial structure of the Asthma Control Test
Algerian version
Dimension 1 Dimension 2
Moroccan version
Dimension 1 Dimension 2
Tunisian version
Dimension 1 Dimension 2
Eigenvalue 1.81 1.19 2.04 1.07 2.23 1.09
Variance explained 36.2% 23.8% 40.7% 21.5% 44.5% 21.8%
Eigenvector
Limitation on activities 0.66 0.06 0.77 0.19 0.84 0.01
Breathlessness 0.62 0.49 0.65 0.31 0.78 0.07
Nocturnal awakenings 0.71 0.23 0.74 0.19 0.74 0.07
Use of rescue treatment 0.002 0.90 0.12 0.92 0.2 0.89
Evaluation of asthma control during the previous
four weeks
0.70 0.29 0.68 0.25 0.58 0.54
Discussion
The objective of the present analysis was to determine the
psychometric properties of dialectical Arabic versions of the
ACT in a large general population sample of individuals with
asthma in three North African countries, Algeria, Morocco
and Tunisia. Although reported levels of asthma control
differed somewhat between countries, being highest in
Tunisia and lowest in Morocco, the psychometric properties
of the questionnaire were qualitatively similar for all three
versions.
In the original validation of the ACT, the internal
consistency of the questionnaire was good (Cronbach’s a
coefﬁcient = 0.84) 8, and satisfactory internal consistency
(Cronbach’s a > 0.80) has been reported in other published
validation studies from other countries 12,19,20, including for
an Arabic version of the ACT evaluated in Lebanon and
Saudi Arabia (Cronbach’s a = 0.92) 21. In the light of these
ﬁndings, it was surprising that the internal consistency
of the ACT in the AIRMAG population was only moderate
(Cronbach’s a = 0.63). We performed serial elimination of
the different items of the ACT in order to identify if
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Fig. 2. Test-retest reproducibility of the Asthma Control Test. Data are pooled between the three versions of the questionnaire and represent scores
obtained from 61 subjects. The diagonal line represents the equivalence line.
Table 6. Relationship between Asthma Control Test scores and variables with a priori associations with asthma control a
Explanatory variables Algerian version Moroccan version Tunisian version
Overall health status
1 = Excellent 6 = Very bad
r = 0.241; p = 0.004 r = 0.378; p < 0.001 r = 0.397; p < 0.001
Asthma inconvenience
1 = Very hampered 4 = Not hampered at all
r = 0.387; p < 0.001 r = 0.315; p < 0.001 r = 0.40; p < 0.001
Limitations in sport and leisure activities
1 = Very limited 4 = Not limited
r = 0.129; p = 0.34 r = 0.022; p = 0.78 r = 0.480; p < 0.001
Limitations in normal physical activity
1 = Very limited 4 = Not limited
r = 0.163; p = 0.20 r = 0.105; p = 0.18 r = 0.259; p = 0.001
Limitations in professional activities
1 = Very limited 4 = Not limited
r = 0.309; p = 0.02 r = 0.208; p = 0.03 r = 0.293; p = 0.004
Limitations in social activities
1 = Very limited 4 = Not limited
r = 0.304; p = 0.02 r = 0.133; p = 0.14 r = 0.347; p < 0.001
Limitations in sleep
1 = Very limited 4 = Not limited
r = 0.397; p < 0.001 r = 0.100; p = 0.17 r = 0.350; p < 0.001
Limitations in lifestyle
1 = Very limited 4 = Not limited
r = 0.285; p = 0.001 r = 0.241; p = 0.002 r = 0.405; p < 0.001
Limitations in household tasks
1 = Very limited 4 = Not limited
r = 0.243; p = 0.01 r = 0.020; p = 0.83 r = 0.469; p < 0.001
a Data are presented as Pearson correlation coefﬁcients (r) and probability values derived from linear regression analysis.
Signiﬁcant associations are highlighted in bold.
any one item was responsible for the reduced internal
consistency observed. This identiﬁed the ‘use of rescue
treatment item as being discordant with the rest. The
explanation of this discordance may relate to limited access
to care in the Maghreb which leads to under-prescription
of short-acting b-agonists (SABA), since only around half
the study sample reported using these drugs 22. Thus,
subjects could report no use of rescue medication either
because their asthma was well-controlled or because it was
poorly controlled but they did not have access to rescue
treatments. It is thus important to take into account the
extent of SABA use when interpreting data obtained with
the ACT in developing countries where such drugs may not
be prescribed systematically to all patients with asthma.
However, access to care is improving rapidly in the Maghreb
and it may be expected that discordance of the ‘use of
rescue treatment’ item will disappear with time. For this
reason, it would be interesting to reassess the internal
consistency of these questionnaires at a future date.
The discordance of the ‘use of rescue treatment’ item
was also demonstrated by the poor correlation of scores
on this item with the other item scores, and by the
relative separation of this item compared with the others
in the primary component analysis. Indeed, in a factorial
analysis of the Spanish version of the ACT, whose internal
consistency was high (Cronbach’s a = 0.84), the factorial
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Table 7. Relationship between Asthma Control Test score and asthma control levels assigned
by an operational GINA-based algorithma
Controlled
N = 45
Partially controlled
N = 244
Uncontrolled
N = 299
p
ANOVA
Algeria (N = 15) (N = 51) (N = 75)
ACT score (mean±SD) 23.3±1.8 19.6±2.4 13.5±2.7 <0.001
Median 24 19 13
Range [20 25] [14 25] [7 18]
Morocco (N = 9) (N = 85) (N = 121)
ACT score (mean±SD) 23.1±1.8 19.4±2.9 12.7±3.4 <0.001
Median 24 20 13
Range [20 25] [13 25] [5 19]
Tunisia (N = 21) (N = 108) (N = 103)
ACT score (mean±SD) 23.7±1.5 19.6±2.6 13.5±3.3 <0.001
Median 24 20 14
Range [19 25] [12 25] [6 19]
a Data were missing for 36 subjects.
Table 8. Relationship between Asthma Control Test score and evolution of asthma since diagnosis
Improved
N = 375
Stable
N = 161
Worsened
N = 78
p
ANOVA
Algeria (N = 71) (N = 48) (N = 22)
ACT score (mean±SD) 17.4±4.6 16.8±4.6 14.5±3.9 0.03
Range [7 25] [11 25] [8 21]
Morocco (N = 151) (N = 43) (N = 21)
ACT score (mean±SD) 16.7±4.6 14.5±4.6 12.5±4.4 <0.001
Range [5 25] [6 24] [6 20]
Tunisia (N = 138) (N = 66) (N = 28)
ACT score (mean±SD) 18.0±4.3 16.6±4.7 15.0±4.6 0.002
Range [8 25] [6 24] [6 25]
structure of the questionnaire was unidimensional 25. In
contrast, for the AIRMAG questionnaires evaluated here,
the four remaining items were effectively aligned along a
single dimension, but the ‘use of rescue treatment’ item
was offset along a second dimension.
In terms of face validity, the ACT score was associated
with a number of variables expected a priori to be
associated with the degree of asthma control, such as
overall health status, asthma inconvenience, limitations
in lifestyle and limitations in professional activity. The
association of poor control with limitations in many ﬁelds
of life emphasises the importance of achieving good asthma
control by appropriate treatment in order to achieve
optimal quality of life.
With regards to discriminant validity, the ACT effectively
discriminated between groups that would be expected
to differ in their level of asthma control. This was the
case for asthma control categories deﬁned according to
an operational GINA-based algorithm, in agreement with a
previous European study 8. Nonetheless, some association
between the two measures should be expected since
some of the ACT items are also included in the GINA-
based algorithm. In addition, ACT scores were higher in
subjects who reported that their asthma had improved
since diagnosis than in those who believed that it had
aggravated.
In conclusion, the ACT appears to be a valid measure of
asthma control in a North African context, even though
its internal consistency is compromised by the ‘use of
rescue treatment’ item. It can thus be proposed as a tool
to measure asthma control in everyday practice in these
countries, as long as SABA use is taken into account in
interpreting the scores. As access to care in the Maghreb
improves, this discrepancy may be expected to disappear.
The availability of a simple, valid and rapidly-completed
control measure such as the ACT in the context of a
more proactive approach to asthma management may help
improve the currently unacceptable level of control of
asthma in the Maghreb.
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